Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
Income from Continuing Operations
Tandem Diabetes Care Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Income from Continuing Operations
-$141.5m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Tandem Diabetes Care Inc's Income from Continuing Operations?
Income from Continuing Operations
-141.5m
USD
Based on the financial report for Mar 31, 2024, Tandem Diabetes Care Inc's Income from Continuing Operations amounts to -141.5m USD.
What is Tandem Diabetes Care Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-7%
Over the last year, the Income from Continuing Operations growth was 31%. The average annual Income from Continuing Operations growth rates for Tandem Diabetes Care Inc have been -79% over the past three years , -5% over the past five years , and -7% over the past ten years .